Quantcast
close
The Wayback Machine - https://web.archive.org/web/20120717010412/http://247wallst.com:80/category/biotech/

Posts related to ‘Biotech’

Looking for the Next Biotech Buyout After Two Drug and Biotech Deals

Posted: July 16, 2012 at 10:43 am

What usually happens when you get two mergers announced in drugs and biotech in the same day? Investors begin to wonder which other peers and competitors might be on the ...
Read Full Story »

Finding the Next Biotech M&A Targets (HGSI, GSK, AMLN, BMY, VRTX, CELG, CBST, AMRN, DNDN, BMRN, VVUS, ARNA, PCYC, VICL, MDGN, AFFX, THRX, RIGL)

Posted: July 10, 2012 at 7:35 am

More biotech mergers are on the way! That is the verdict of Wall St. There may be patent protection risks associated with future regulation under health care, but deals in ...
Read Full Story »

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

Posted: July 3, 2012 at 7:35 am

GlobeImmune, Inc. is the latest biotech to file for an initial public offering.  Financial terms were not disclosed but the first filing is for up to $69 million in common ...
Read Full Story »

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

Posted: July 2, 2012 at 2:42 pm

The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value may be a bit misleading if you consider that it ...
Read Full Story »

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Posted: June 30, 2012 at 9:45 am

Some mergers are very straight-forward, and others are just odd.  Now we have an answer over whether or not Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) was going to be acquired or ...
Read Full Story »

Trader Watch: Will Arena Raise More Capital Now?

Posted: June 27, 2012 at 2:25 pm

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is surging after the FDA approved its weight loss pill called BELVIQ.  In fact, now that shares have reopened after having been halted this stock ...
Read Full Story »

Arena Obesity Pill Approved, Good For All Fat-Fighters (ARNA, VVUS, OREX, AGN)

Posted: June 27, 2012 at 1:22 pm

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) was halted today for news that the company's weight-loss drug called BELVIQ has been approved.  The news is good for all obesity drug makers today.  ...
Read Full Story »

Are the Teva/Momenta MS Patent Reactions Too Large?

Posted: June 25, 2012 at 3:30 pm

Teva Pharmaceutical Industries Limited (NYSE: TEVA) are up 4.7% a $39.75 on more than 12 million shares, while Momenta Pharmaceuticals Inc. (NASDAQ: MNTA) are down over 22% at $13.19 on ...
Read Full Story »

Friday Turned Into Biotech Friday, Many Massive Movers On News

Posted: June 22, 2012 at 4:05 pm

How many big movers can you see in one day in the biotech sector?  This is what investors should be asking.  If you didn't know better you might think there ...
Read Full Story »

Repligen Sets Up To Be The Implosion Of The Day (RGEN)

Posted: June 22, 2012 at 8:53 am

Repligen Corporation (NASDAQ: RGEN) may be the biotech implosion of the day if the volume starts to catch up to some pre-market trading levels.  The company received a complete response ...
Read Full Story »

Onyx Pharma Becomes Stock of the Day

Posted: June 21, 2012 at 9:36 am

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) was already on the radar screens in biotech before this morning.  But news showing that the company's cancer drug carfilzomib has received favorable FDA panel ...
Read Full Story »

Biotech Implosion Day at Celgene

Posted: June 21, 2012 at 8:30 am

Celgene Corporation (NASDAQ: CELG) is supposed to be one of the more promising biotechs out there.  After all it was worth some $29.6 billion in market capitalization at Wednesday's close.  ...
Read Full Story »

A New Royalty Stream For PDL Bio (PDLI)

Posted: June 19, 2012 at 8:01 am

PDL BioPharma, Inc. (NASDAQ: PDLI) appears to have a new royalty stream coming its way.  The company announced this morning that it is now set to start receiving royalty payments ...
Read Full Story »

Arena Volume Spike Highlights Weight Loss Sector Again, Volatility To Continue (ARNA, VVUS, OREX)

Posted: June 13, 2012 at 12:55 pm

We are tracking and analyzing a significant volume spike in shares of Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today.  Shares are up nearly 5% at $8.25 and the 12:30 PM trading ...
Read Full Story »

Is Amylin Already At Full M&A Value Even Before It Is Announced? (AMLN, AZN, SNY, MRK, BMY, PFE)

Posted: June 5, 2012 at 8:16 am

Amylin Pharmaceuticals Inc. (NASDAQ: AMLN) is back in the rumor mill as far as a buyout, but this time the price appears to be more finite.  We have heard enough ...
Read Full Story »